Key result
Percutaneous retrograde CoreValve implantation was successfully performed in a high-risk patient with a degenerated aortic bioprosthesis, resulting in NYHA functional class I at follow-up.
Case Report (n=1)
Demonstrates the feasibility of transcatheter valve-in-valve implantation as a treatment for degenerated aortic bioprostheses in high-risk surgical candidates.
No takes yet. Share an insight, caveat, or question.
May support valve-in-valve TAVR in select high-risk patients; leaves open need for prospective validation.
Bruschi et al. (2010) conducted a case report in Aortic bioprosthesis structural degeneration (n=1). Percutaneous retrograde CoreValve implantation was evaluated on Procedural success and NYHA functional class at follow-up. Percutaneous retrograde CoreValve implantation was successfully performed in a high-risk patient with a degenerated aortic bioprosthesis, resulting in NYHA functional class I at follow-up.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: